Latest Breaking News On - Hans moebius - Page 1 : comparemela.com

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesMark littonSharay settiHans moebiusRachel leningtonSherif redaAthira pharmaJulie rathbunAlzheimer association international congressMotor neurone disease associationSociety for neuroscience sfn annual meetingSecurities exchangeInternational symposiumExchange commissionClinical development pipeline programsDevelopment rd expenses

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesDeepika jalotaAdi hoessMarc fellousMax bayerMolly gibsonDaiichi sankyoHans moebiusRobert califfPaolo martiniJulie tierneyRamin farzanehAdam perlmanRob scottCelia linAbionyx pharma

Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update

Completed enrollment in Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease and expects topline data in second half of 2024 Plans to.

United statesMark littonHans moebiusJulie rathbunAthira pharmaSecurities exchangeMotor neurone disease associationExchange commissionAlzheimer association international congressAthira pharma incAmyotrophic lateral sclerosis consortiumAmerican association of neurologyManagement teamChief executive officerChief medical officerSenior scientific advisor

Athira Pharma (ATHA) Reports Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton

Athira Pharma (ATHA) Reports Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark littonHans moebiusAthira pharma incKevin churchAthira pharmaChief medical officerChief scientific officerChief executive officer

Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson s Disease Dementia and Dementia with Lewy Bodies

Exploratory findings add to increasing body of clinical and preclinical data supporting positive modulation of the neurotrophic HGF system as a potential therapeutic approach for neurodegenerative.

United statesAthira pharmaMark littonJulie rathbunHans moebiusExchange commissionAthira pharma incKevin churchSecurities exchangeChief medical officerChief scientific officerChief executive officerGlobal statistical testSecurities actSecurities exchange actPrivate securities litigation reform act